InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Peter Neupert. Officer active across 1 company, notably Adaptive Biotechnologies Corporation. Aggregated, 1 filings have been logged. History available since 17 August 2026. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.